Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

Target Validation Information
TTD IDTTDS00129
Target NameSigma(1)-type opioid receptor    
Type of TargetSuccessful target    
Drug Potency against TargetDextromethorphanIC50 = 2500 nM[1]
OPC-14523IC50 = 2.3 nM[2]
OPC-14523IC50 = 2.3 nM[3]
E-5842IC50 > 100000 nM[4]
DITOLYLGUANIDINEKi = 60 nM[5]
Ref 1Curr Top Med Chem. 2006;6(8):749-70.N-methyl-D-aspartate receptor (NMDA) antagonists as potential pain therapeutics. To Reference
Ref 2Neuropharmacology. 2001 Dec;41(8):976-88.Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523. To Reference
Ref 3Curr Top Med Chem. 2008;8(12):1008-23.5-HT1 receptor augmentation strategies as enhanced efficacy: therapeutics for psychiatric disorders. To Reference
Ref 4Mini Rev Med Chem. 2008 Oct;8(12):1243-51.Recent advances in the research of HIV-1 RNase H inhibitors. To Reference
Ref 5J Med Chem. 1994 Jun 10;37(12):1737-9.Synthesis and characterization of [125I]-N-(N-benzylpiperidin-4-yl)-4- iodobenzamide, a new sigma receptor radiopharmaceutical: high-affinity binding to MCF-7 breast tumor cells. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543